A$287.12
0.52% today
Australia, Oct 20, 07:10 am CET
ISIN
AU000000COH5
Symbol
COH

Cochlear Stock price

A$287.12
-5.71 1.95% 1M
+28.02 10.81% 6M
+1.64 0.57% YTD
+1.83 0.64% 1Y
+100.38 53.75% 3Y
+78.90 37.89% 5Y
+213.97 292.53% 10Y
+263.93 1,138.14% 20Y
Australia, Closing price Mon, Oct 20 2025
+1.48 0.52%
ISIN
AU000000COH5
Symbol
COH

Key metrics

Basic
Market capitalization
A$18.7b
Enterprise Value
A$18.7b
Net debt
positive
Cash
A$275.7m
Shares outstanding
65.4m
Valuation (TTM | estimate)
P/E
48.2 | 41.0
P/S
8.0 | 7.1
EV/Sales
8.0 | 7.1
EV/FCF
138.6
P/B
9.6
Dividends
DPS
A$4.30
Yield 1Y | 5Y
1.5% | 1.5%
Growth 1Y | 5Y
4.9% | 21.9%
Payout 1Y | 3Y
72.5% | 73.5%
Increased
5 Years
Financials (TTM | estimate)
Revenue
A$2.3b | A$2.6b
EBITDA
- | A$707.1m
EBIT
A$532.5m | A$613.4m
Net Income
A$388.9m | A$456.2m
Free Cash Flow
A$135.0m
Growth (TTM | estimate)
Revenue
4.8% | 12.0%
EBITDA
- | -
EBIT
0.2% | 15.2%
Net Income
9.0% | 17.3%
Free Cash Flow
-54.9%
Margin (TTM | estimate)
Gross
74.2%
EBITDA
- | 27.0%
EBIT
22.7%
Net
16.6% | 17.4%
Free Cash Flow
5.8%
Financial Health
Equity Ratio
69.0%
Return on Equity
19.9%
ROCE
24.0%
ROIC
19.0%
Debt/Equity
0.1
More
EPS
A$5.9
FCF per Share
A$2.1
Short interest
-
Employees
5k
Rev per Employee
A$460.0k
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Cochlear forecast:

7x Buy
37%
10x Hold
53%
2x Sell
11%

Analyst Opinions

19 Analysts have issued a Cochlear forecast:

Buy
37%
Hold
53%
Sell
11%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,343 2,343
5% 5%
100%
- Direct Costs 606 606
12% 12%
26%
1,738 1,738
2% 2%
74%
- Selling and Administrative Expenses 940 940
5% 5%
40%
- Research and Development Expense 292 292
5% 5%
12%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 533 533
0% 0%
23%
Net Profit 389 389
9% 9%
17%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,047
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today